Our pharma cold-chain network passed its annual GDP audit with zero major findings across all 22 validated lanes.
This development comes as global supply chains continue to adapt to shifting demand patterns, regional sourcing, and the broader sustainability transition. Our teams have been investing across digital infrastructure, sustainable fleet, and warehousing capacity to keep pace with customer needs.
We will continue to publish updates as new milestones are reached. For media inquiries, please contact our press desk.